Immuneering Corp (IMRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-25.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $317.0K | $2.08M | $2.31M | — |
| Cost of Revenue | — | — | $0 | $158.1K | $1.15M | $1.28M | — |
| Gross Profit | — | — | $0 | $158.8K | $926.9K | $1.03M | — |
| Operating Income | -$59.38M | -$64.07M | -$58.41M | -$51.74M | -$33.89M | -$17.08M | — |
| Net Income | -$56.02M | -$61.04M | -$53.47M | -$50.51M | -$33.54M | -$17.04M | — |
| EPS (Diluted) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | — |
| Total Assets | $231.99M | $52.71M | $102.58M | $122.37M | $166.70M | $38.42M | — |
| Total Liabilities | $13.50M | $11.33M | $12.01M | $12.52M | $10.72M | $2.80M | — |
| Shareholders' Equity | $218.48M | $41.39M | $90.58M | $109.85M | $155.98M | -$22.48M | -$6.53M |
| Cash & Equivalents | $128.65M | $36.14M | $59.41M | $72.64M | $74.89M | $37.09M | — |
| Operating Cash Flow | -$45.34M | -$55.00M | -$48.97M | -$44.10M | -$30.85M | -$14.62M | — |
| Capital Expenditures | $142.2K | $84.9K | $342.7K | $742.5K | $60.8K | $53.4K | — |
| Shares Outstanding | 44.01M | 29.98M | 28.42M | 26.39M | 13.61M | 4.95M | — |